Side-by-Side Overview
BPC-157 vs. TB-500 at a Glance
Two structurally distinct peptides with overlapping research contexts — separated by origin, mechanism, and primary study areas.
| Parameter | BPC-157 | TB-500 |
|---|---|---|
| Full name | Body Protection Compound-157 | Thymosin Beta-4 active fragment |
| Amino acid count | 15 (pentadecapeptide) | 43 (TB-4 fragment Ac-SDKP extended) |
| Molecular origin | Derived from gastric juice protein sequence | Synthetic fragment of thymus gland protein TB-4 |
| Primary research areas | GI mucosa integrity, angiogenesis, nitric oxide pathway signaling, CNS models | Actin sequestering (Tβ4–G-actin binding), cell migration, vascular research, fibroblast studies |
| Indexed published studies | 200+ | 150+ |
| PubMed reference | Search BPC-157 on PubMed ↗ | Search TB-4 fragment on PubMed ↗ |
| Supply form | Lyophilized powder, sterile vial | Lyophilized powder, sterile vial |
| Purity standard (SL) | ≥99% — verified via HPLC + MS | ≥99% — verified via HPLC + MS |
| COA | Batch-specific, Krause Analytical | Batch-specific, Krause Analytical |
| Available sizes at SL | 5mg ($38.99) · 10mg ($60.99) | 5mg ($52.99) · 10mg ($97.99) |
| Blend available | BPC-157 + TB-500 Blend — 5mg each — $70.99 | |
Individual Research Profiles
Understanding Each Compound
Body Protection Compound-157
Pentadecapeptide · 15 amino acids · Gastric origin
BPC-157 is a synthetic pentadecapeptide with a sequence partially derived from a gastric juice protein. It has been investigated across 200+ published studies since its initial characterization in the early 1990s. Research has examined its role in multiple tissue and cellular contexts, with particular focus on gastrointestinal mucosa models, nitric oxide pathway modulation, and angiogenic signaling cascades.
- Gastrointestinal mucosal integrity and cytoprotection models
- Nitric oxide (NO) pathway modulation in research systems
- Angiogenesis — VEGF signaling and vascular network formation in vitro
- Central and peripheral nervous system tissue research models
- Tendon and ligament fibroblast proliferation studies
- Counteraction of NSAID-induced gastric lesion models
Thymosin Beta-4 Active Fragment
43-amino acid fragment · TB-4 origin · Thymus protein
TB-500 is a synthetic peptide corresponding to a bioactive fragment of Thymosin Beta-4 (Tβ4), a 43-amino acid protein originally isolated from the thymus. Tβ4 is one of the most abundant intracellular peptides in mammalian tissue. Published research has examined its role in G-actin sequestration, cytoskeletal dynamics, and cell migration, with over 150 indexed studies across vascular, cardiac, and structural tissue research models.
- Actin sequestering — Tβ4 binds G-actin monomers, regulating cytoskeletal dynamics
- Cell migration and wound healing in vitro models
- Angiogenesis — endothelial cell differentiation and vessel formation
- Cardiac tissue research models following ischemic events
- Fibroblast and keratinocyte proliferation studies
- Anti-inflammatory cytokine research (IL-10, NF-κB pathway contexts)
Research on Combined Use
Studying BPC-157 and TB-500 Together
BPC-157 and TB-500 have been studied within the same research contexts — particularly in angiogenesis, structural tissue research, and fibroblast models. Their mechanisms are biochemically distinct: BPC-157 primarily modulates nitric oxide signaling and growth factor expression, while TB-500 operates through G-actin sequestration and cytoskeletal regulation.
Published research has begun to examine these compounds in combination, hypothesizing that their non-overlapping pathways may provide a broader scope of study in single experimental designs. Some investigators have noted complementary activities in vascular and structural tissue contexts.
Sequence Labs offers a pre-formulated BPC-157 + TB-500 blend for researchers who wish to study both compounds simultaneously — eliminating the need to prepare separate research samples.
View All Research Compounds →Available Now · Sequence Labs
BPC-157 + TB-500 Blend
5mg BPC-157 + 5mg TB-500 · Single lyophilized vial
per vial · for research use only
- Pre-blended — no separate reconstitution required
- Batch-specific COA via Krause Analytical
- HPLC + mass spec verified for both compounds
- ≥99% purity per component
- reviewed by Sabrina Runbeck, PA-C inclusion
- Wholesale pricing available
Research Selection Guide
How to Choose for Your Research
Research context should guide compound selection. The two peptides target distinct molecular pathways — understanding the primary mechanisms in each research context helps determine which compound, or whether the combination, is appropriate for a given experimental design.
Research contexts for BPC-157
BPC-157 is the more studied compound for GI-mucosa research and nitric oxide pathway work. Its broader literature base makes it the more documented choice for initial mechanistic studies in several contexts.
- Gastrointestinal mucosal integrity models
- Nitric oxide (eNOS / nNOS) pathway investigations
- VEGF-driven angiogenesis models
- Tendon fibroblast and ligament tissue research
- Central nervous system tissue models
- Counteraction of NSAID-associated gastric lesion models
Research contexts for TB-500
TB-500 is the primary choice for actin dynamics and cytoskeletal research. Its well-characterized G-actin binding mechanism makes it the appropriate compound for cell migration and structural cytoskeletal work.
- G-actin sequestration and cytoskeletal dynamics
- Cell migration — endothelial and fibroblast assays
- Cardiac tissue research following ischemic models
- Keratinocyte and fibroblast proliferation studies
- Anti-inflammatory pathway research (NF-κB, IL-10)
- Vascular endothelial differentiation studies
Frequently Asked Questions
Ready to order for your research?
Browse the full Sequence Labs catalog, view batch-specific COAs, or apply for wholesale access. All compounds are independently verified by Krause Analytical.